Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (761-770 of 962) with videos related to

Pageof 97
Sort By:
International Journal of Cardiology|August 5, 2020
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trialKuniaki Takahashi, Rutao Wang, Hideyuki Kawashima, et al.
Nature Reviews. Cardiology|January 19, 2020
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular diseaseDavide Capodanno, Deepak L Bhatt, John W Eikelboom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 21, 2020
Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trialMasafumi Ono, Mariusz Tomaniak, Wolfgang Koenig, et al.
Journal of the American College of Cardiology|April 6, 2016
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery DiseaseMarc P Bonaca, Deepak L Bhatt, Robert F Storey, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
European Heart Journal|September 3, 2015
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)Michel Komajda, Franz Weidinger, Mathieu Kerneis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor TherapyEsther Reijnders, Patrick M Bossuyt, J Wouter Jukema, et al.
The New England Journal of Medicine|April 21, 2016
One-Year Risk of Stroke after Transient Ischemic Attack or Minor StrokePierre Amarenco, Philippa C Lavallée, Julien Labreuche, et al.
Journal of the American College of Cardiology|June 12, 2003
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational StudyAlan S Maisel, James McCord, Richard M Nowak, et al.
Circulation. Cardiovascular Interventions|February 10, 2012
Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL studyPatrick Ohlmann, Philippe Reydel, Laurent Jacquemin, et al.
Pageof 97

Showing results (761-770 of 962) with videos related to

Sort By:
Pageof 97
International Journal of Cardiology|August 5, 2020
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trialKuniaki Takahashi, Rutao Wang, Hideyuki Kawashima, et al.
Nature Reviews. Cardiology|January 19, 2020
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular diseaseDavide Capodanno, Deepak L Bhatt, John W Eikelboom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 21, 2020
Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trialMasafumi Ono, Mariusz Tomaniak, Wolfgang Koenig, et al.
Journal of the American College of Cardiology|April 6, 2016
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery DiseaseMarc P Bonaca, Deepak L Bhatt, Robert F Storey, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
European Heart Journal|September 3, 2015
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)Michel Komajda, Franz Weidinger, Mathieu Kerneis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor TherapyEsther Reijnders, Patrick M Bossuyt, J Wouter Jukema, et al.
The New England Journal of Medicine|April 21, 2016
One-Year Risk of Stroke after Transient Ischemic Attack or Minor StrokePierre Amarenco, Philippa C Lavallée, Julien Labreuche, et al.
Journal of the American College of Cardiology|June 12, 2003
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational StudyAlan S Maisel, James McCord, Richard M Nowak, et al.
Circulation. Cardiovascular Interventions|February 10, 2012
Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL studyPatrick Ohlmann, Philippe Reydel, Laurent Jacquemin, et al.
Pageof 97